Nightingale Health Oyj has developed a biomarker profiling technology widely used in population health research. Nightingale has measured biomarkers from 40,000 samples from THL biobank cohorts. The aim of this THL Biobank project is to continue research on the existing NMR biomarker data for precision medicine research. The research will also help further developments of this technology in healthcare. The project duration has been extended by THL Biobank. Here the data analyst team is updated.
Ändringar i tillståndet: ändring av personuppgiftshandläggarna
Utfärdare av det ursprungliga tillståndet: Findata; annan än Findata